RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability

12Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Faithful replication and DNA repair are vital for maintenance of genome integrity. RAD51 is a central protein in homologous recombination repair and during replication, when it protects and restarts stalled replication forks. Aberrant RAD51 expression occurs in glioma, and high expression has been shown to correlate with prolonged survival. Furthermore, genes involved in DNA damage response (DDR) are mutated or deleted in human glioblastomas, corroborating the importance of proper DNA repair to suppress gliomagenesis. We have analyzed DDR and genomic instability in PDGF-B-induced gliomas and investigated the role of RAD51 in glioma development. We show that PDGFB- induced gliomas display genomic instability and that co-expression of RAD51 can suppress PDGF-B- induced tumorigenesis and prolong survival. Expression of RAD51 inhibited proliferation and genomic instability of tumor cells independent of Arf status. Our results demonstrate that the RAD51 pathway can prevent glioma initiation and maintain genome integrity of induced tumors, suggesting reactivation of the RAD51 pathway as a potential therapeutic avenue. © The Author(s) 2011.

Cite

CITATION STYLE

APA

Westermark, U. K., Lindberg, N., Roswall, P., Bråsäter, D., Helgadottir, H. R., Hede, S. M., … Uhrbom, L. (2011). RAD51 can inhibit PDGF-B-induced gliomagenesis and genomic instability. Neuro-Oncology, 13(12), 1277–1287. https://doi.org/10.1093/neuonc/nor131

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free